Concepedia

Rosemary Cobb

RC

Statistics

Publications

5

Citations

241

H-Index

5

Active since

2020

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Rutgers, The State University of New Jersey

Technion – Israel Institute of Technology

University of California, Davis

Rosemary Cobb is an author at Massachusetts General Hospital specializing in medicine, molecular oncology, and oncology.

Publications per year

2020–2023

5

Publications

5

Therapy-induced APOBEC3A drives evolution of persistent cancer cells

Hideko Isozaki, Ramin Sakhtemani, Ammal Abbasi et al. · Nature · 2023 · 145 citations · Full text

Medicine, Cancer Biology, Molecular Genetics +12

Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study

Jingran Ji, Jacqueline V. Aredo, Andrew J. Piper‐Vallillo et al. · JTO Clinical and Research Reports · 2023 · 39 citations · Full text

Medicine, Oncology, Pharmacology +16

Clinical and Imaging Features of Non–Small-Cell Lung Cancer in Young Patients

Sherief Garrana, Ibiayi Dagogo‐Jack, Rosemary Cobb et al. · Clinical Lung Cancer · 2020 · 21 citations · Full text

Medicine, Oncology, Radiology +16

Osimertinib in non-small cell lung cancer (NSCLC) with atypical EGFR activating mutations: A retrospective multicenter study.

Jingran Ji, Jacqueline V. Aredo, Andrew J. Piper‐Vallillo et al. · Journal of Clinical Oncology · 2020 · 18 citations

Medicine, Oncology, Pharmacology +17

APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer

Hideko Isozaki, Ammal Abbasi, Naveed Nikpour et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 18 citations

Life Sciences, Genetics, Oncology +14

1–5 of 5